ES375013A1 - Pyrrolobenzodiazepinone derivatives - Google Patents

Pyrrolobenzodiazepinone derivatives

Info

Publication number
ES375013A1
ES375013A1 ES375013A ES375013A ES375013A1 ES 375013 A1 ES375013 A1 ES 375013A1 ES 375013 A ES375013 A ES 375013A ES 375013 A ES375013 A ES 375013A ES 375013 A1 ES375013 A1 ES 375013A1
Authority
ES
Spain
Prior art keywords
formula
pyrrolobenzodiazepinone
compound
derivatives
arylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES375013A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44050780A external-priority patent/JPS4843755B1/ja
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES375013A1 publication Critical patent/ES375013A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Abstract

A procedure for the preparation of a new pyrrolobenzodiazepinone compound of the formula: **(See formula)** where R is lower alkyl oxy, arylalkyl (lower) oxy, lower alkyl) thio, arylalkyl (lower) thio or dialkyl (lower) amino, which consists in reacting a compound of formula **(See formula)** with a compound of formula R-H, where R is as defined above. (Machine-translation by Google Translate, not legally binding)
ES375013A 1968-12-30 1969-12-29 Pyrrolobenzodiazepinone derivatives Expired ES375013A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8368 1968-12-30
JP44050780A JPS4843755B1 (en) 1969-06-26 1969-06-26

Publications (1)

Publication Number Publication Date
ES375013A1 true ES375013A1 (en) 1972-03-01

Family

ID=26332992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES375013A Expired ES375013A1 (en) 1968-12-30 1969-12-29 Pyrrolobenzodiazepinone derivatives

Country Status (6)

Country Link
ES (1) ES375013A1 (en)
FI (1) FI46259C (en)
GB (1) GB1299198A (en)
IE (1) IE33906B1 (en)
IL (1) IL33558A (en)
RO (1) RO55813A (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464467A (en) * 1982-07-26 1984-08-07 Bristol-Myers Company Antitumor antibiotics produced by new streptomyces
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
AU757510C (en) * 1998-08-27 2003-09-11 Medimmune Limited Pyrrolobenzodiazepines
GB9818732D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
US6909006B1 (en) 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
PT2270010E (en) 2004-03-01 2012-03-12 Spirogen Ltd 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins
GB0404577D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
US7528126B2 (en) 2004-03-09 2009-05-05 Spirogen Limited Pyrrolobenzodiazepines
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
BR112012026410B8 (en) 2010-04-15 2023-01-31 Spirogen Dev Sarl COMPOUND AND CONJUGATE OF PYROLOBENZODIAZEPINE AND USES THEREOF
JP5870400B2 (en) 2010-04-15 2016-03-01 シアトル ジェネティクス，インコーポレーテッド Targeted pyrrolobenzodiazepine conjugates
GB201006340D0 (en) 2010-04-15 2010-06-02 Spirogen Ltd Synthesis method and intermediates
KR101860174B1 (en) 2011-09-20 2018-05-21 메디뮨 리미티드 Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
WO2013053872A1 (en) 2011-10-14 2013-04-18 Spirogen Sàrl Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
CN103987384A (en) 2011-10-14 2014-08-13 西雅图基因公司 Pyrrolobenzodiazepines and targeted conjugates
WO2013053873A1 (en) 2011-10-14 2013-04-18 Spirogen Sàrl Pyrrolobenzodiazepines
WO2013055993A1 (en) 2011-10-14 2013-04-18 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
EP2751110B1 (en) 2011-10-14 2017-04-19 MedImmune Limited Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative and autoimmune diseases
EP2906296B1 (en) 2012-10-12 2018-03-21 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
PL2906253T3 (en) 2012-10-12 2019-02-28 Adc Therapeutics Sa Pyrrolobenzodiazepine - anti-psma antibody conjugates
EP2906249B1 (en) 2012-10-12 2018-06-27 MedImmune Limited Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
CN110256469B (en) 2012-10-12 2022-05-17 麦迪穆有限责任公司 Pyrrolobenzodiazepines and conjugates thereof
US10695433B2 (en) 2012-10-12 2020-06-30 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
RS56520B1 (en) 2012-10-12 2018-02-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
US9931414B2 (en) 2012-10-12 2018-04-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
LT2839860T (en) 2012-10-12 2019-07-10 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
WO2014057114A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-anti-psma antibody conjugates
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
EP3054983B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054985B1 (en) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
US10780096B2 (en) 2014-11-25 2020-09-22 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
JP6671555B2 (en) 2017-02-08 2020-03-25 アーデーセー セラピューティクス ソシエテ アノニム Pyrrolobenzodiazepine antibody conjugate
AU2018255876B2 (en) 2017-04-18 2020-04-30 Medimmune Limited Pyrrolobenzodiazepine conjugates
US20200129637A1 (en) 2017-04-20 2020-04-30 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
AU2018285562B2 (en) 2017-06-14 2024-01-18 Adc Therapeutics Sa Dosage regimes for the administration of an anti-CD19 ADC
AU2018316532B2 (en) 2017-08-18 2022-11-24 Medimmune Limited Pyrrolobenzodiazepine conjugates
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof

Also Published As

Publication number Publication date
FI46259B (en) 1972-10-31
GB1299198A (en) 1972-12-06
IL33558A0 (en) 1970-04-20
FI46259C (en) 1973-02-12
IE33906B1 (en) 1974-12-11
IE33906L (en) 1970-06-30
RO55813A (en) 1974-02-01
IL33558A (en) 1973-10-25

Similar Documents

Publication Publication Date Title
ES375013A1 (en) Pyrrolobenzodiazepinone derivatives
ES310240A1 (en) A procedure to prepare a deep polyuclean indol. (Machine-translation by Google Translate, not legally binding)
ES457993A1 (en) Isothiazolo-pyridines
ES388614A1 (en) Mutilin derivatives
ES395380A1 (en) N-phenylthiocarbamoylthio-hydroximate pesticides
ES405456A1 (en) 7-Alkoxycarbonyl-4-hydroxymethyl-1-phthalazone compounds
ES317623A1 (en) A procedure for the preparation of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
ES401898A1 (en) Benzofuran derivatives and processes therefor
ES332657A1 (en) Method to prepare tiadiazoles. (Machine-translation by Google Translate, not legally binding)
GB1307646A (en) 5-hydroxycoumarin derivatives
GB1229993A (en)
GB1325944A (en) Bisoxalic acid diamides
ES383433A1 (en) Procedure for preparing pirrol derivatives. (Machine-translation by Google Translate, not legally binding)
ES442988A1 (en) Preparation of salicylamide derivatives
ES391118A1 (en) Novel glucuronic acid derivatives and process for the preparation thereof
ES329067A1 (en) Procedure for the preparation of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
ES381209A1 (en) 1,2-diphenyl-3,5-dioxo-4-substituted pyrazolidines
ES377775A1 (en) Procedure for the obtaining of ester bis- (N-meticarbamico) of 2,6-piridindimetanol. (Machine-translation by Google Translate, not legally binding)
ES457708A1 (en) Process for preparation of 3-hydroxymethylcephems
ES316075A1 (en) Procedure for the production of tropan derivatives. (Machine-translation by Google Translate, not legally binding)
ES461191A1 (en) New nn**11piperidinyl*alkyl* aryl carboxysamide derivative
GB1021530A (en) Derivatives of 2-oxo-2h-1,4-benzoxazine
ES293287A1 (en) Procedure for obtaining a new compound for the control of hypertension (Machine-translation by Google Translate, not legally binding)
ES331239A3 (en) A procedure for preparing fenotiazine compounds. (Machine-translation by Google Translate, not legally binding)
ES460287A1 (en) A procedure for the obtaining of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)